M Science launches Australia Spending Trends Platform

KUALA LUMPUR, May 30 (Bernama) -- M Science, the pioneer in data-driven research and analytics, has announced the launch of its Australia Spending Trends Platform, an initiative marking an expansion of the firm's increasing global presence.

Derived from M Science’s leading-edge data, the new platform provides daily, weekly, monthly and semi-annual visibility into competitive benchmarking and consumer behaviours and details customer spending patterns for more than 130 Global and Domestic Australian brands, including food delivery services, grocery stores, DTC platforms and travel agencies.

According to a statement, companies include Just Eat, Deliveroo, Woolworths, JbHifi, Afterpay, Temple and Webster and Harvey Norman, with M Science continuing to enhance its list of merchants across a broad spectrum of industries.

“We are thrilled to bring this consumer spending solution to market for Australian focused investors and companies, increasingly providing our investors and corporate clients with a comprehensive global view into consumer behaviour,” said Valentin Roduit, Head of International.

“For the first time, investors and companies have detailed, data-driven visibility into consumer spending in Australia with our new Australia Spending Trends Platform,” said John Tomlinson, CFA/CPA, Global Director of Research, adding the new offering enabled indepth insights and understanding of spending trends that were previously a blind spot for investors, corporate clients and businesses.

The launch of the Australia Spending Trends Platform yields a new, unparalleled layer of business performance analysis providing global companies and investors proprietary near real-time insight into Australian consumer behaviour and competitive analytics.

M Science has displayed rapid growth in 2022. Earlier this year, the firm launched Sundial, a new data platform that empowers organisations and data buyers to discover, explore and connect with alternative data in the most transparent, trusted and efficient way.

M Science is a portfolio company of Leucadia Investments, a division of Jefferies Financial Group Inc. with offices in New York, London, Hong Kong, and Portland, Oregon.

For more information, visit https://www.mscience.com/.

-- BERNAMA

Crocus Technology announces release of high accuracy energy metering solution

KUALA LUMPUR, May 25 (Bernama) -- Crocus Technology Inc, developer of XtremeSense® TMR sensors, has announced the release of a high accuracy energy metering solution with isolated current sensing and digital output.

“The Crocus solution with the CT430 current sensor provides improved accuracy over existing magnetic sensor based designs,” said Tim Kaske, Crocus Vice President, Sales & Marketing. 

“With a validated design solution and a 12-week lead-time, OEM design customers are able to quickly integrate the energy metering solution into their end products.”

The solution is capable of measuring power, voltage and current while providing 1,820 VPK isolation in AC or DC applications. The result is a smaller and more efficient design without the use of large current transformers. 

According to a statement, the solution is ideal for a range of smart devices such as power supply monitors, electric vehicle chargers, household appliances, motor control and smart lighting.

The solution consists of the Crocus’ CT430 TMR isolated current sensor, Microchip’s ATtiny426 microcontroller, Printed Circuit Board (PCB), design files, microcontroller firmware, Bill of Materials (BoM) list, user guide and relevant support for designing a fully functional power monitoring solution.

The design solution has been verified to accurately read and quantise the voltage and current values prior to calculating the instantaneous and Root Mean Square (RMS) power components, active and reactive power, as well as power factor.

These power values are stored in registers which can be accessed by an external microcontroller via the SPI interface. By offloading the design effort of measuring and calculating power, the Crocus metering solution simplifies the addition of metering capabilities to any smart device.

The key to precise power measurements is the CT430 current sensor which provides better than one per cent current measurement accuracy over the -40°C to +125°C operating range.

It is available in a small 16-lead SOIC-Wide package, eliminating the need for bulky current transformers and allowing for more compact designs. 

More details at www.crocus-technology.com.

-- BERNAMA

nib nz insurance limited Credit Ratings withdrawn - AM Best

KUALA LUMPUR, May 27 (Bernama) -- Global credit rating agency, AM Best has removed from under review with developing implications and affirmed the Financial Strength Rating of A- (Excellent) and the Long-Term Issuer Credit Rating of ‘a-’ (Excellent) of nib nz insurance limited (nib nz insurance) New Zealand.

According to a statement, the outlook assigned to these Credit Ratings (ratings) is stable. Concurrently, AM Best has withdrawn the ratings as the company has requested to no longer participate in AM Best’s interactive rating process.

These rating actions follow the completed acquisition of 100 per cent ownership of Kiwi Insurance Limited (Kiwi Insurance) on April 29, 2022, by nib nz holdings limited (nib nz holdings).

The transaction, previously announced in November 2021, also includes the establishment of an exclusive relationship with Kiwibank Limited (Kiwibank), which will see the bank refer its retail customers to nib nz holdings for their life insurance needs. Following the transaction, Kiwi Insurance has been renamed as nib nz insurance.

The ratings reflect nib nz insurance’s balance sheet strength, which AM Best assesses as strong, as well as its adequate operating performance, neutral business profile and appropriate enterprise risk management (ERM).

In addition, the ratings factor in a neutral impact from the company’s ultimate ownership by nib holdings limited (nib group), a health insurer listed on the Australian Stock Exchange (ASX) that provides health insurance in Australia and New Zealand.

nib nz insurance’s balance sheet strength assessment is underpinned by its risk-adjusted capitalisation, as measured by Best’s Capital Adequacy Ratio (BCAR), which was at the strongest level as of fiscal year-end 2021 and is expected to remain at this level over the medium term.

This reflects the company’s moderate underwriting leverage and conservative investment allocation. Over the medium term, AM Best expects full earnings retention to support the company’s business initiatives.

Based on an assessment of the credit fundamentals of nib group, as well as consideration of the perceived strategic importance and integration of nib nz insurance to the group, no rating lift or drag has been applied to nib nz insurance’s ratings.

More details at www.ambest.com.

-- BERNAMA

TDCX unveils first quarter 2022 financial results

KUALA LUMPUR, May 26 (Bernama) -- TDCX Inc (TDCX or the Company), an award-winning digital customer experience (CX) solutions provider for technology and blue-chip companies, has announced its unaudited financial results for the first quarter ended March 31, 2022.

In a statement, Chief Executive Officer and Founder of TDCX, Laurent Junique said: “Despite the volatile operating environment, we stayed focused on executing and delivering our plans to achieve a strong first quarter performance. Our performance demonstrates the grit and resilience of our people and the strong foundation that we have built for our business.

“Since our last earnings announcement, we have added new key clients, including a leading global short-form video social media platform and a leading Southeast Asia e-commerce platform. Later this month, TDCX will also be included in the MSCI Global Small Cap Index.

“Looking ahead, growing geopolitical and economic instabilities may create headwinds for our business, primarily in the short term. However, we remain optimistic about our market opportunities and long-term growth potential.”

First Quarter 2022 Financial Highlights include total revenue of US$112.6 million, representing 26.9 per cent year-on-year growth; Adjusted Net Income of US$22.3 million, representing 34.9 per cent year-on-year growth; and, Q1 2022 Net Cash from Operating Activities of US$37.1 million, representing 188.1 per cent year-on-year growth. (US$1 = RM4.392)

Meanwhile, Business Highlights include added 10 new logos in Q1 2022, more than double the four logos added in Q1 2021; 55 clients as of March 31, 2022, a 41 per cent increase as compared with 39 clients as of March 31, 2021; and, Reinforced Global English capabilities with the launch of a new campus in Hyderabad, India.

Singapore-headquartered TDCX provides transformative digital CX solutions, enabling world-leading and disruptive brands to acquire new customers, to build customer loyalty and to protect their online communities.

TDCX employs more than 14,000 employees across 26 campuses globally, specifically Singapore, Malaysia, Thailand, the Philippines, Mainland China, Hong Kong, South Korea, Japan, India, Romania, Spain and Colombia.

More details at www.tdcx.com.

-- BERNAMA

Tricor Group offers insights on global market expansion focusing ASEAN

KUALA LUMPUR, May 26 (Bernama) -- Following last year’s relatively subdued global economic rebound, the economies of Association of Southeast Asian Nations (ASEAN) are well positioned for growth and foreign direct investment (FDI) in 2022 and beyond, according to Tricor Group’s ASEAN in Focus: Economic Outlook, Insights & Business Opportunities.

It is a compilation of business insights to guide multinational companies (MNCs), SMEs and entrepreneurs interested in establishing, operating and scaling business growth across ASEAN.

Tricor Group CEO, Lennard Yong said: “The passage of the RCEP trade bloc is a defining moment for global trade and a pivotal development that will inevitably redirect FDI flows in the months and years ahead. Notably, the maturing economies of ASEAN serve as a linchpin for activating the deal.

“At Tricor, we are keeping a strong pulse on how this landmark agreement is triggering new global trade trends, bolstering pan-Asian supply chains and expanding opportunities for foreign investors. Tricor’s specialised local expertise and dynamic connections reinforce our status as the ‘go-to’ partner for enterprises seeking to expand throughout ASEAN, APAC and beyond.”

The report offers perspectives, observations and analyses from senior Tricor executives on how global trade trends are impacting trade, investment and global market expansion in the economies of ASEAN.

According to a statement, the report contains a special section on the landmark signing of the Regional Comprehensive Economic Partnership (RCEP).

Connecting 15 countries and covering 30 per cent of the world’s population as part of the largest trading bloc globally, the RCEP is expected to reduce tariffs at between 90 per cent and 93 per cent of cross-border tariff lines.

The report also contains an overview of each ASEAN market, with dedicated sections for business incorporation, tax considerations and the labour environment.

Key highlights from Tricor’s ASEAN in Focus: Economic Outlook, Insights & Business Opportunities include a deep dive into business incorporation, tax considerations and the labour environment for each of the 10 ASEAN economies; and, an exploration of how ASEAN is serving as a growth engine for the investment and expansion strategies of MNCs from mainland China.

Together with Tricor's services and expertise, the guidance provided in the report arms companies with profound insights to further business objectives and take advantage of the latest global trade trends transforming ASEAN, APAC and beyond.

More details at www.tricorglobal.com.

-- BERNAMA

CROCUS DELIVERS THE FUTURE OF HIGH PRECISION, HIGH CURRENT CONTACTLESS ISOLATED CURRENT SENSE

The CT45x showcases the advantages of TMR sensors to rethink and simplify solutions in the high precision, high current application space

MILPITAS, Calif., May 24 (Bernama-GLOBE NEWSWIRE) -- Crocus Technology Inc., the leading supplier of disruptive TMR (Tunnel Magneto-Resistance) XtremeSense® sensors, today announced the CT45x family of contactless isolated current sensors to enable high precision and high current measurements in a more simplified solution. Unlike existing solutions, the CT45x allows manufacturers to eliminate costly shields, concentrators or cores. The CT452 and CT453 offers contactless 0.7% accuracy, 1 MHz bandwidth, and better than -50 dB immunity to external magnetic fields without additional mechanical components. This combination of performance and accuracy enables customers to reduce their overall product size and weight which enables them to replace large and costly current sense modules with a small and simple solution.

As current requirements have been increasing so have the challenges of accurately measuring high currents, typically >200 A and often up to 2,000 A. Shunt resistors with isolated amplifiers are broadly used but present an issue with I²R losses and tend to be large and costly. Existing magnetic based solutions like Hall Effect and AMR are less accurate and have high temperature drift. The CT45x products are based on XtremeSense TMR technology that delivers the future with a high signal-to-noise ratio (SNR) contactless approach which can scale with the system requirements, high bandwidth and fast response time, common-model field rejection, combined with high accuracy measurements over temperature.

In addition, many applications now require very accurate current measurements in the milliamp range up to the 1,000 A range or more. Often this type of solution involves multiple current sensors to achieve the desired system performance with many design compromises and complexities. Using Crocus’ XtremeSense TMR current sensors allows for a no-compromise and simple solution using a single CT45x sensor which provides a large dynamic range and a high SNR. For example, the CT45x is able to measure down to 500 mA resolution and up to 1,800 A while maintaining better than 0.7% accuracy.

The CT45x offers groundbreaking noise performance, as low as 0.55 mV_RMS, to enable applications to sense small current levels and small changes or variations in current through a busbar. This performance is almost 10 times better than existing Hall Effect solutions. This results in a SNR (signal-to-noise ratio) as high as 77 dB for the CT45x measurement which allows the system to process higher resolution data with higher accuracy. 

http://mrem.bernama.com/viewsm.php?idm=43221

PUBMATIC'S CONNECT ENABLES MEDIA BUYERS SEAMLESSLY LINK UP WITH TARGET AUDIENCES

KUALA LUMPUR, May 25 (Bernama) -- PubMatic, an independent technology company delivering digital advertising’s supply chain of the future, has announced the launch of Connect, a comprehensive and fully integrated platform to enable media buyers to seamlessly connect with their target audiences across the open internet. 

“As media buyers seek to maximise the value and ROI of their media spend, audience addressability is a critical piece of the puzzle,” said VP, Addressability at PubMatic, Peter Barry in a statement.

“Connect sets a new standard for efficiency and effectiveness in media targeting, giving advertisers access to specific audiences using the data currency they prefer, in one streamlined platform. There is a robust future for sell-side audience addressability, and this will give publishers and advertisers better control over revenue and performance.”

Connect is one of the only unbiased addressability offerings that combines many of the preferred signal approaches into one platform, including known identity, first and second-party data, contextual signals, seller-defined audiences, and modelled audiences.

The solution enables brands and media buyers to activate a portfolio approach to addressability to improve ad relevance while respecting consumer privacy, well ahead of the ecosystem's transition away from the third-party cookie.

Connect builds on the momentum of the company’s audience business, which has increased over 3x in the past year, thanks in part to strong growth drivers such as supply path optimisation deals and PubMatic’s connected TV (CTV) business.

By bringing audience targeting to the sell-side of the digital advertising ecosystem, PubMatic’s Connect provides ad buyers with greater control over how inventory and data are packaged and transacted to drive the best performance for their campaigns.

As a result, buyers get sustainable audience resolution, increased reach and scale, and greater return on ad spend – across display, video, mobile app, and CTV.

Connect unites a portfolio of addressability solutions that PubMatic has developed over the past few years into a single platform, making it easier for buyers to access and activate various data signals across channels.

-- BERNAMA

NIPPON EXPRESS HOLDINGS SUPPORTS RECOMMENDATIONS OF TCFD

KUALA LUMPUR, May 24 (Bernama) -- Nippon Express Holdings Inc has recently expressed its support for the recommendations of the Task Force on Climate-related Financial Disclosures (TCFD) established by the Financial Stability Board (FSB).

According to a statement, the NX Group has identified climate change initiatives as one of the key issues (materialities) to be addressed in realising its long-term vision of becoming ‘a logistics company with a strong presence in the global market’.

In addition, it is working to reduce CO2 emissions in its own business operations as well as creating products and services that help customers cut their CO2 emissions.

The NX Group will be utilising the TCFD's recommendations henceforth to analyse the risks and opportunities presented by climate change to its business, evaluate their financial impacts, and disclose relevant information.

The NX Group is scheduled to make the first such disclosure following endorsement of the recommendations in its integrated report to be issued this fiscal year (in June 2022).

TCFD is an international initiative established by the FSB in 2015 to encourage companies to disclose information on the financial impact of climate change risks and opportunities on their businesses.

The TCFD recommends assessing the financial impacts of climate change risks and opportunities on management and disclosing information on ‘governance’, ‘strategies’, ‘risk management’, and ‘indicators and targets’.

The NX Group will continue practising sustainable management from a long-term perspective to help realise a sustainable society by tackling climate change.

More details at https://www.nipponexpress.com/

-- BERNAMA

Crocus unveils CT45x family of contactless isolated current sensors

KUALA LUMPUR, May 24 (Bernama) -- Crocus Technology Inc, the leading supplier of disruptive TMR (Tunnel Magneto-Resistance) XtremeSense® sensors, has announced the CT45x family of contactless isolated current sensors to enable high precision and high current measurements in a more simplified solution.

“With the introduction of the CT45x family of contactless current sense products, we now have a complete portfolio of products for our customers from small currents to larger currents,” said President and CEO of Crocus Technology, Zack Deiri.

“This product based on Crocus’ cutting-edge TMR technology is the most exciting for us as the benefits of our XtremeSense TMR are addressing the needs of higher current applications that can’t be met with existing solutions without compromises.”

According to a statement, unlike existing solutions, the CT45x allows manufacturers to eliminate costly shields, concentrators or cores.

The CT452 and CT453 offers contactless 0.7 per cent accuracy, 1 MHz bandwidth, and better than -50 dB immunity to external magnetic fields without additional mechanical components.

This combination of performance and accuracy enables customers to reduce their overall product size and weight which enables them to replace large and costly current sense modules with a small and simple solution.

The CT45x products are based on XtremeSense TMR technology that delivers the future with a high signal-to-noise ratio (SNR) contactless approach which can scale with the system requirements, high bandwidth and fast response time, common-model field rejection, combined with high accuracy measurements over temperature.

The CT45x offers groundbreaking noise performance, as low as 0.55 mVRMS, to enable applications to sense small current levels and small changes or variations in current through a busbar.

This performance is almost 10 times better than existing Hall Effect solutions. This results in a SNR (signal-to-noise ratio) as high as 77 dB for the CT45x measurement which allows the system to process higher resolution data with higher accuracy.

More details at http://www.crocus-technology.com.

-- BERNAMA

CDW HOLDING UPDATES ON DIVERSIFICATION EFFORTS AND SUSTAINABILITY DIRECTION

 

• 
  As part of its diversification efforts, the Group has been pursuing new business opportunities which are aimed at transforming traditional industries to be more environment-friendly and to improve human life
• The diversification businesses span diverse industries like drug development, skincare, clean energy, and water purification
• Adopts UN Sustainable Development Goals as a framework to guide diversification efforts

SINGAPORE, May 24 (Bernama-GLOBE NEWSWIRE) -- SGX Mainboard-listed CDW Holding Limited (“CDW”, the “Company”, or collectively with its subsidiaries, the “Group”) is pleased to share an update on its diversification efforts and announce a new strategic direction for the Group, centred around the United Nations’ Sustainable Development Goals (“UN SDGs”).

CDW’s Diversification Efforts
The Group is a leading manufacturer of LCD Backlight Units for applications in various industries such as computer, automotive, and gaming and has recently also built up a promising OEM business in producing electronic payments systems and digital content editing devices. As the Group operates in a challenging industry with intense price competition and shortening product life cycles, it embarked on a diversification strategy in 2016 to identify other potential areas of growth and made its foray into Bio & life sciences and other businesses.

Bio & Life Sciences
The Group holds a patent for a synthetic antibody library through its subsidiary GSP Enterprise Inc. (“GSP”), which was established by the late Honorary Professor Shimizu Nobuyoshi of Keio University and acquired by the Company in 2018. GSP builds upon the late Professor Shimizu Nobuyoshi’s fundamental research in the medical field through developing specific antibodies to target tumours, viruses or other diseases, with the aim of creating immunotherapies for them. A Biotech Co., Ltd (“ABio”) was established in South Korea at the same time for antibody-related research and development.

The Group had previously announced key milestones in the development of novel antibody drugs aimed at treating various cancers. The most promising candidate thus far, the anti-Cripto-1 antibody, was patented in September 2020 and has been shown to be effective at inhibiting the self-proliferation of cancer stem cells. Recent anti-Cripto-1 antibody research have been led by ABio, which is conducting a pre-clinical efficacy study at the National Cancer Centre of Korea.

“The late Professor Emeritus Nobuyoshi Shimizu of Keio University passed away from cancer in 2015 after founding GSP to commercialize his research. In 2018, we acquired GSP to continue the late Professor Shimizu's legacy and advance his cancer drug development fundamental research, and help more people suffering from cancer globally. ABio was established at the same time and is currently continuing its research in collaboration with GSP,” said Mr Yoshikawa Makoto, the Chairman and Chief Executive Officer of the Group.

Apart from aiming to treat serious illnesses through fundamental research, the Group has also made strides in addressing the growing consumer demand for beauty and wellness. The Group acquired Intellectual Property Rights in 2016 related to the functional use and manufacture of organic compounds including Pterostilbene Glycoside products which have antioxidant, anti-aging and hair growth benefits. In addition, the Group is also looking to licence out its recently acquired patent on the cancer stem cell growth inhibitory effect of pterostilbene and/or its glycosides.

In September 2021, the Group announced the launch of its own skincare brand YOSHIMI JAPAN following five years of research and development into the anti-aging pterostilbene glycoside compound, which was shown to have greater efficacy at addressing the anti-wrinkle segment of topical beauty products. The product is currently available online to consumers in Japan, China, Hong Kong, and Singapore. A licensing agreement has also been signed with a Japanese cosmetics manufacturer to use pterostilbene glycoside in various product lines of the cosmetics manufacturer’s customers, with product launches scheduled to begin later in 2022.

Environment-Friendly Products and Technologies
As a contract manufacturer, CDW is keenly aware of the carbon footprint and environmental impact that can be caused by traditional industries. That is why it has been actively pursuing new business opportunities in environmental products and technologies which include clean energy and nanomaterials.

In July 2021, the Group secured the rights to distribute CUBOX portable lithium-ion battery packs for use in industrial, household and medical settings in Japan.

The Group has also obtained the global distributorship rights to Japanese alkaline water generator brand, Nihon Trim Co.,Ltd¹. (“TRIM”). The deal will allow the Group to capture new opportunities as the demand for alkaline water generators grows around the world. According to market research firm Global Information Inc., the global water ionizer market is estimated to grow at a CAGR of 4.22% to reach over US$ 1.6 billion by 2027. The global distributorship will see the Group distribute TRIM’s products in overseas countries, excluding Indonesia and Guangdong province in China. The Group is already exporting and selling its products to some countries and regions.

CDW has also secured the exclusive rights to market in Japan and distribute electric boat propulsion systems that are developed by Electrine² of Korea (formerly known as LGM Co., Limited, with which the Company has a 2.3% stake), a leading Korean electric boat building company, with currently discussions for the rights to Hong Kong and Singapore ongoing. The electric boat propulsion system was the first electric propulsion unit in Japan to qualify for pre-inspection. The advantage of electric ship propulsion unit is that they require no fossil fuels, thus enabling the realisation of decarbonisation. Additionally, the Company will also develop and sell fuel-efficient and environment-friendly ship-bottom paints which use nanomaterial technology. Further research is underway to improve the efficacy of ship-bottom paints samples being tested on marine vessels.

The Group also exhibited its electric boat propulsion systems and ship-bottom paints at the Japan International Boat Show³, Japan's largest ship-related exhibition, held from 31 March to 3 April 2022. Several potential customers, including large leisure facility operators, were given the opportunity to meet with the Group and negotiations are underway for sales. The Japan International Boat Show is also being held in an online venue from 18 March to 31 August 2022, and still exhibiting.

Adopting the UN SDG Framework
In order to focus its diversification efforts, the Group has decided to adopt a strategic framework that is centred around the UN SDGs, which consists of 17 goals and 169 targets. Adopted at the UN Summit in September 2015, the goals were set by 193 UN member countries to be achieved in 15 years from 2016 to 2030.

In particular, the last few years have seen a renewed focus among institutional investors on environmental, social, and governance, or ESG standards. The scars of the global pandemic, as well as mounting concerns over the impact of environmental degradation from industrial activity around the world have led to a growing demand for sustainability solutions.

“CDW has always been exploring opportunities in the areas of health and environment. This would further enhance our attractiveness to institutional investors, as we continue to strengthen our revenue streams and diversify our competencies beyond LCD backlight units,” remarked Mr Yoshikawa Makoto.

Meeting the growing ESG demand
With investments in ESG trending, and CDW believes that its new strategic direction is the right step forward to meet that growing demand from institutional investors. Bloomberg forecasts that ESG Assets Under Management (“AUM”) could grow to US$53tn by end-2025, having already reached US$30.6tn by end-2021. On the debt-issuance front, ESG-themed issuance took almost 12 years from 2007, to reach US$1tn but just one year to reach USD2tn over 2020. In just the first six months of 2021, it crossed another US$1tn and is estimated to surpass USD11tn by end-2025.

About CDW Holding Limited                (www.cdw-holding.com.hk)

CDW Holding Limited (the “Company” and together with its subsidiaries, the “Group”) is a Japanese-managed precision components specialist serving the global market focusing on the production and supply of niche precision components for mobile communication equipment, gamebox entertainment equipment, consumer and information technology equipment, office equipment and electrical appliances. The Group is headquartered in Hong Kong and has operations in Japan, China and the Philippines. The Company has been identifying new businesses to invest in with the potential for growth and entered as part of its diversification strategy and has made forays into the Life Sciences sector since 2016. The Company’s aim for its Life Sciences business is to identify research-driven yet commercializable projects that can have a positive impact on the quality of human life.

Issued on behalf of : CDW Holding Limited
Contact : Ivan Hong / Gerald Woon
Office : (65) 6704 9288
Email / DID / Mobile : ivanhong@cogentcomms.com / (65) 6704 9287 / (65) 9055 8883
woon@cogentcomms.com / (65) 6704 9268 / (65) 9694 8364 


¹ Listed on the Tokyo Stock Exchange TRIM’s alkaline water generators are being used across a wide variety of settings; ranging from the home, to hospitals, commercial, and agricultural businesses. https://www.nihon-trim.co.jp/english/
² http://www.electrine.co.kr/main
³ https://online.boatshow.jp/exhibitors/tomoike/ 


SOURCE : CDW Holding Limited

Customer data platform revenue reaches US$6 billion by 2027 - Juniper Research

KUALA LUMPUR, May 24 (Bernama) -- A new study by Juniper Research has found customer data platform providers will generate US$6 billion globally by 2027, rising from US$1.7 billion in 2022; representing growth of 250 per cent, with the introduction of AI-based services being key to unifying multiple data sources on a single platform; reducing siloed data and centralising enterprise access to customer data. (US$1 = RM4.392)

According to a statement, customer data platforms are used to gain insight into customer preferences through collecting and extrapolating data on transactions, browsing history and other online information.

The new research, Customer Data Platforms: Key Strategies, Competitor Leaderboard & Market Forecasts 2022-2027, urges customer data platforms to increase the breadth of integrations with third‑party vendors, such as relationship management platforms, for greater access to user data.

It highlighted the ability of customer data platforms to merge different data sources using AI as critical to unlocking more granular user insights to inform highly targeted marketing campaigns, enable greater personalisation and increase return on advertising spend.

The research assessed leading customer data platforms in the market; evaluating them on key factors, such as product offerings, partnerships and innovation, with the top three vendors ranked as Oracle; Salesforce; and, Tealium.

In addition, the report predicts that the retail and eCommerce sector will represent 35 per cent of global customer data platform revenue in 2022, as online competition drives enterprise requirements for indepth customer insights.

In turn, the report urges customer data platform providers to develop new services that cater to online retailers and recommends that investment be focused on creating more efficient personalisation services.

Juniper Research provides research and analytical services to the global hi-tech communications sector, providing consultancy, analyst reports and industry commentary.

-- BERNAMA

Dawex co-CEO speaks at World Economic Forum Annual Meeting in Davos

Live Session at Davos (Photo: Dawex)

KUALA LUMPUR, May 24 (Bernama) -- Dawex, the leading technology company for data exchange, data marketplace and data hub, has announced co-CEO Fabrice Tocco would speak at the World Economic Forum Annual Meeting in Davos.

He will also share his vision on creating new data exchange ecosystems to respond to environmental and economic challenges, according to a statement.

The live session at Davos with Dawex “Strengthening Trust in Public-Private Data Exchanges” will take place on May 24 at 1:30pm CET.

Data ecosystems have become a fundamental component of business competitiveness and economic sovereignty.

In today’s economy where data has become a product of unlimited potential, with its own value, and a source of new revenue streams, Dawex technology allows organisations to create new ecosystems around data exchange platforms that meet regulatory requirements and address traceability and security challenges.

Created in 2015, Dawex is headquartered in France, expanding business operations to Europe, Asia, North America and the Middle East.

-- BERNAMA

LATE-BREAKING RESULTS SHOW EFFICACY FOR CCM IN PATIENTS WITH HFPEF

 Investigators Report Positive Findings From Feasibility Study of CCM in Heart Failure With Preserved Ejection Fraction at the European Society of Cardiology Heart Failure 2022 Congress


MADRID and MARLTON, N.J., May 24 (Bernama-GLOBE NEWSWIRE) -- Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure (HF), announced today a late-breaking presentation of results from the CCM-HFpEF Piloty Study, which is the largest clinical trial to date studying the effects of the company’s proprietary CCM® therapy to treat HF with preserved ejection fraction (HFpEF). The results presented — including a substantial 18 point improvement in the Kansas City Cardiomyopathy Questionnaire (KCCQ) quality of life score — indicate that, for patients with heart failure and left ventricular ejection fraction (LVEF) ≥50%, CCM therapy not only offered meaningful improvement in quality of life but also substantially decreased hospitalizations versus the patient’s experience prior to the Optimizer® implant. The results were presented at the European Society of Cardiology’s Heart Failure 2022 Congress.

Patients with HFpEF suffer from debilitating symptoms and have very few therapeutic options. This patient population is a similar size as the one with reduced ejection fraction and has been shown to have similar struggles with quality of life, hospitalizations, and mortality. 

Cecilia Linde, MD, Professor and Consultant in Cardiology at the Heart and Vascular Theme of Karolinska University Hospital and the Karolinska Institute in Stockholm, Sweden, who was the co-principal investigator for this investigation, said, “The CCM-HFpEF Pilot Study was conducted to explore the hypothesis that CCM therapy might benefit patients with HFpEF. Our hypothesis was based on evidence of greater benefits in CCM HFrEF studies in those with higher LVEF range and from case reports of HFpEF patients. In our CCM-HFpEF-Pilot Study, we found significant benefits from CCM therapy in patients with preserved LVEF, supporting prior findings. I look forward to following the progress of the recently begun pivotal AIM HIGHer trial to continue this journey further.”

Dr. Ishu Rao, Medical Director for Impulse Dynamics, welcomed these results because they confirm the potential for positive results in the company’s recently initiated AIM HIGHer trial. “We are also excited to announce that enrollment is well underway for this landmark IDE-approved, multicenter, randomized, and blinded pivotal trial designed not only to confirm Dr. Linde’s groundbreaking work presented today but to go further yet by providing the first long term morbidity and mortality results for a modern Optimizer CCM device. While Dr. Linde specifically studied patients with EFs ≥50%, in AIM HIGHer, we are examining the efficacy of CCM therapy in 1,500 patients with EFs between 40% and 60%. This represents a large cohort of patients who currently have minimal treatment options and are clamoring for help. If AIM HIGHer's results are consistent with Dr. Linde’s findings, we may finally begin to close the significant gap in care that exists for millions of patients afflicted with HF and higher EF.”

HF affects more than 64 million people worldwide and leads to dramatic declines in a patient’s quality of life. Patients are often classified by a measure of cardiac function known as the ejection fraction (EF), which describes the percentage of blood pumped out of the left ventricle with each heartbeat. CCM therapy is currently indicated in Europe for patients that have an EF below 50% and has been proven to reduce hospitalizations. However, HF patients with higher EF have had few therapeutic options thus far to alleviate their symptoms and treat their disease.

The purpose of the AIM HIGHer trial — the largest randomized, sham-controlled, device-based interventional heart failure trial — is to further assess the potential of CCM to improve performance and reduce cardiovascular morbidity and mortality for these patients. CCM therapy for HFpEF has already received the FDA’s breakthrough device designation. The Breakthrough Devices Program is a voluntary program for certain medical devices that provide more effective treatment or diagnosis of life-threatening or irreversibly debilitating diseases or conditions. The goal of the Breakthrough Devices Program is to provide patients and health care providers with timely access to these medical devices by speeding up their development, assessment, and review while preserving the statutory standards consistent with the Agency's mission to protect and promote public health.

The Optimizer Smart Mini delivers CCM therapy which consists of precisely timed electrical pulses sent to the heart. These signals are designed to improve the heart’s ability to function properly, allowing more oxygen-rich blood to be pushed out through the body.

About Impulse Dynamics

Impulse Dynamics, based in Marlton, NJ, is dedicated to helping healthcare providers enhance the lives of people with heart failure by transforming how the condition is treated. The company has pioneered CCM® therapy, which is delivered by the company’s Optimizer® Smart Mini, an FDA-approved treatment verified to improve the quality of life for certain heart failure patients. CCM therapy is a safe, effective, and minimally invasive treatment option for many heart failure patients who otherwise have few effective options available to them. To learn more, visit www.ImpulseDynamics.com, or follow the company on LinkedIn, Twitter, and Facebook.

Forward-looking Statements

This press release contains forward-looking statements. All statements other than statements of historical facts contained in this press release are forward-looking statements. In some cases, you can identify forward-looking statements by terms such as ‘‘may,’’ ‘‘will,’’ ‘‘should,’’ ‘‘expect,’’ ‘‘plan,’’ ‘‘anticipate,’’ ‘‘could,’’ ‘‘intend,’’ ‘‘target,’’ ‘‘project,’’ ‘‘contemplate,’’ ‘‘believe,’’ ‘‘estimate,’’ ‘‘predict,’’ ‘‘potential’’ or ‘‘continue’’ or the negative of these terms or other similar expressions, although not all forward-looking statements contain these words. Forward-looking statements include, but are not limited to, statements concerning: potential benefits of CCM therapy and the ability for CCM therapy and our products to fill a significant unmet medical need for patients with heart failure; and the short-term and long-term benefits of the Optimizer Smart Mini and CCM therapy in patients with heart failure, as well as to the physicians treating those patients. These forward-looking statements are based on management’s current expectations and involve known and unknown risks and uncertainties that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Other important factors that could cause actual results, performance or achievements to differ materially from those contemplated in this press release include, without limitation: the Company’s future research and development costs, capital requirements and the Company’s needs for additional financing; commercial success and market acceptance of CCM therapy; the Company’s ability to achieve and maintain adequate levels of coverage or reimbursement for Optimizer Smart and Optimizer Smart Mini systems or any future products the Company may seek to commercialize; competitive companies and technologies in the industry; the Company’s ability to expand its indications and develop and commercialize additional products and enhancements to its current products; the Company’s business model and strategic plans for its products, technologies and business, including its implementation thereof; the Company’s ability to expand, manage and maintain its direct sales and marketing organization; the Company’s ability to commercialize or obtain regulatory approvals for CCM therapy and its products, or the effect of delays in commercializing or obtaining regulatory approvals; FDA or other U.S. or foreign regulatory actions affecting us or the healthcare industry generally, including healthcare reform measures in the United States and international markets; the timing or likelihood of regulatory filings and approvals; and the Company’s ability to establish and maintain intellectual property protection for CCM therapy and products or avoid claims of infringement. The Company does not undertake any obligation to update forward-looking statements and expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein. These forward-looking statements should not be relied upon as representing the Company’s views as of any date subsequent to the date of this press release.

###

Rex Richmond, Director (Media Relations)
Impulse Dynamics
856-642-9933
rrichmond@impulsedynamics.com

Harriss Currie, CFO (Investor Relations)
Impulse Dynamics
856-642-9933
hcurrie@impulsedynamics.com

Ian Segal, Manager (Public Relations)
Impulse Dynamics
856-642-9933
isegal@impulsedynamics.com 

SOURCE : Impulse Dynamics

ADVANCE LOCAL IS NEW SOPHI.IO CUSTOMER

TORONTO, May 19 (Bernama-GLOBE NEWSWIRE) -- Advance Local, one of the largest media groups in the United States operating 10 leading news and information organizations and reaching 55 million people monthly, has quadrupled their subscription goal using Sophi Content Paywall Engine. Faced with advertising pressures exacerbated by the Coronavirus, Advance Local increased subscription conversions 45% using Sophi.io, an AI-powered automation, optimization and prediction platform developed by The Globe and Mail. Their success with Sophi has also earned them a spot as a finalist in the Digiday Media Awards, announced this week.

Neil Katz, Chief Customer Officer at Advance Local, said, “We wanted to see how much farther Sophi could take us, so we tested Sophi Content Paywall on one of our largest sites. The results were transformative. We were hoping for a 10% lift in conversion rate and Sophi delivered four times that result. We’re continuing to roll out Sophi solutions across more of our sites as we speak.”

Advance started using Sophi Content Paywall Engine on one of its largest sites, cleveland.com, to get better insights into the value of their content and fuel their new subscription business. The technology uses advanced natural language processing (NLP) to analyze every piece of content and select which articles to put behind a paywall. It picks only those articles where the subscription revenue opportunity outweighs the advertising revenue forgone.

During an experiment where Advance could see how Sophi performed side by side with their existing paywall, Sophi presented roughly the same amount of paywalls and generated a 45% lift in the total conversion rate, while also uncovering pockets of content that editors didn't anticipate would generate subscriptions.

John Hassell, Senior Vice President and Editorial Director at Advance Local, said, “We wanted to see if Sophi’s content paywall could increase subscriber acquisition by 10% and it blew that goal out of the water. We’re feeling good about the platform and the way it is showing us just how valuable our editorial content is to our audience.”

Advance Local is also a finalist in the Digiday Media Awards, in the category of Best Subscription or Membership Product, for their work using Sophi Content Paywall Engine.

“Advance Local is an incredibly innovative organization that we've watched push the boundaries and we’re very excited to be working with them,” said Mike O’Neill, Co-Founder and CEO of Sophi.io. “We’re seeing great value come from the content paywall they’ve implemented and we’re excited to introduce some other cutting edge technology into this very strong brand.” 

http://mrem.bernama.com/viewsm.php?idm=43192

Melo now brand-new sterilised retail shop in Singapore

KUALA LUMPUR, May 18 (Bernama) -- During Post-Covid in Singapore, with Innovation & Technology from Japan, now Melo, managed by Global Partners Consulting Group, is introducing the brand-new sterilised retail shop in Singapore to ensure its customers and staff can visit and work at the shop with comfort.

Managing director, Zenta Nishida said in a statement that even with strong government support in Singapore to contain and improve on the COVID era, he believed some commercial side could contribute to get the economy back to pre-COVID times.

“By our collaboration with Japan Trust Chemical Co Ltd, our retail shop now becomes fully sterilised for our dear customers and hard-working staff. My top priority is always safety of my staff and I hope other business owners feel the same to set higher standards in Singapore together.”

Proven technology from Japan, provided by Japan Trust Chemical Co Ltd shows outstanding results “once mist touched, it shows results of no germ or virus within 15 seconds through three minutes.”

Melo would like its shoppers to feel safer in this environment and to lead all of the retail shop environment with this advanced technology solution in Singapore.

GPC Group is a consulting firm specialising in assisting Japanese companies expand their business in Asia with offices in Tokyo, Singapore, Hong Kong, Vietnam, and Cambodia.

More details at http://www.gpc-gr.com.

-- BERNAMA